PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label BOEHRINGER INGELHEIM. Show all posts

Showing posts with label BOEHRINGER INGELHEIM. Show all posts

Boehringer Ingelheim Started safety of OFEV Study

Boehringer Ingelheim announces the initiation of clinical trial, a new 12 week study to assess the safety, tolerability and pharmacokinetic...

SANOFI AND BOEHRINGER INGELHEIM ON BUSINESS SWAP

Sanofi and Boehringer Ingelheim announced that the companies have entered into exclusive negotiations to swap businesses. The proposed tra...

Boehringer Ingelheim and MD Anderson Cancer Center in Collaboration

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center announced a collaboration focused on developing innovative med...

Boehringer Ingelheim initiates efficacy and safety of BI 1482694

Boehringer Ingelheim announced at the BIO-Europe® conference in Munich, Germany, the initiation of a global Phase II trial evaluating the ...

Boehringer Ingelheim licenses Vectron Biosolutions’ expression technology platform

Boehringer Ingelheim, a research-based, global pharmaceutical company, announced today the licensing of Vectron Biosolutions’ expression t...

View web version

Powered by Blogger.